Mostrar el registro sencillo del ítem

dc.contributor.authorCastillo Ramos, Ventura 
dc.contributor.authorGarcía Reyes, Cinthia Berenice
dc.contributor.authorMangas García, Guillermo
dc.contributor.authorSampedro Quesada, María Inmaculada 
dc.contributor.authorMartínez-Checa Barrero, Fernando José 
dc.contributor.authorSánchez Polo, Manuel 
dc.date.accessioned2023-02-09T11:55:31Z
dc.date.available2023-02-09T11:55:31Z
dc.date.issued2022-11-21
dc.identifier.citationRamos, V.C... [et al.]. ZIF-8 and Its Magnetic Functionalization as Vehicle for the Transport and Release of Ciprofloxacin. Pharmaceutics 2022, 14, 2546. [https://doi.org/10.3390/pharmaceutics14112546]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/79790
dc.description.abstractThe use of nanomaterials for the controlled release of drugs aims to enhance their effectiveness, especially when poorly soluble in water, and achieve their rapid, localized, and effective administration. The present study focuses on the use of a Zeolitic Imidazolate Framework-8 (ZIF-8) as vehicle for the transport and controlled release of the antibiotic ciprofloxacin (CIP) as model due to its favorable physicochemical characteristics. The objective is to synthesize the ZIF-8 material loaded with CIP through encapsulation for subsequent release of the drug in neutral and acid physiological media. In addition, functionalization of the CIP/ZIF compound with magnetic nanoparticles (NP) was sought to increase its traceability through the possible use of magnetic fields. Characterizations by XRD, FT-IR, SEM-EDX, and TGA showed a satisfactory synthesis of both pure ZIF-8 and ciprofloxacin-loaded ZIF-8, with high crystallinity and thermal stability. The release profiles showed an abrupt initial release that stabilized over time. A much higher release (20–80% greater) was obtained in acid versus neutral pH in all cases, attributable to the collapse of the ZIF-8 structure in acid media. In addition, functionalization of the material with iron NPs did not affect the behavior of the system during drug release. Antimicrobial activity tests against E. coli and S. aureus showed that ZIF-8 per se exerts antimicrobial activity, while the compounds CIP/ZIF and magnetic CIP/ZIF increased the antimicrobial capacity of pure CIP by 10–20%. The ZIF-8 system has high potential as a drug carrier and release agent for the treatment of diseases, especially those that cause acidification of the cellular environment, achieving a rapid, localized, and targeted action with the possibility of achieving traceability of the system after its magnetic functionalization.es_ES
dc.description.sponsorshipP18-RT-4193es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMetal organic frameworkses_ES
dc.subjectMagnetic ZIF-8es_ES
dc.subjectDrug releasees_ES
dc.subjectCiprofloxacin es_ES
dc.subjectPharmaceuticales_ES
dc.titleZIF-8 and Its Magnetic Functionalization as Vehicle for the Transport and Release of Ciprofloxacines_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/pharmaceutics14112546
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional